Risedronate increases BMD at the hip, spine and radius in postmenopausal women with low bone mass

被引:0
|
作者
McClung, MR
Bensen, W
Bolognese, MA
Bonnick, SL
Ettinger, MP
Harris, ST
Heath, H
Lang, R
Miller, PD
Pavlov, EP
Silverman, SL
Woodson, GC
Faulkner, KJ
Bekker, PJ
Axelrod, DW
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:P269 / P269
页数:1
相关论文
共 50 条
  • [1] Lasofoxifene increases the spine and hip BMD and decreases bone turnover markers in postmenopausal women with low or normal BMD
    McClung, M.
    Siris, E.
    Cummings, S.
    Bone, H.
    Recker, R.
    Delmas, P.
    Zanchetta, J.
    Lewiecki, M.
    Zerbini, C.
    Miller, S.
    Wolter, K.
    Proulx, J.
    Brunell, R.
    Radecki, D.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S7 - S7
  • [2] Risedronate increases BMD at the hip and spine in elderly, osteoporotic women.
    Geusens, P
    Burge, D
    Zippel, H
    Songcharoen, S
    Walravens, M
    Trapp, R
    Sod, E
    Digennaro, J
    Bos, K
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S287 - S287
  • [3] Risedronate therapy increases total hip BMD in postmenopausal women independent of initial hip BMD status
    Benhamou, CL
    Chesnut, C
    Roux, C
    Wasnich, R
    Goemaere, S
    Greenwald, M
    Diamond, T
    Adami, S
    Ethgen, D
    Eastell, R
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S172 - S172
  • [4] Risedronate is effective in increasing BMD in both early and late postmenopausal women with low bone mass
    Bekker, PJ
    McClung, MR
    Bensen, W
    Bolognese, MA
    Bonnick, SL
    Ettinger, MP
    Harris, ST
    Heath, H
    Lang, R
    Miller, PD
    Pavlov, EP
    Silverman, SL
    Woodson, GC
    Faulkner, KJ
    Axelrod, DW
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : S474 - S474
  • [5] Lasofoxifene increased BMD of the spine and hip and decreased bone turnover markers in postmenopausal women with low or normal BMD.
    McClung, M
    Siris, E
    Cummings, S
    Bone, H
    Recker, R
    Delmas, P
    Zanchetta, J
    Lewiecki, M
    Zerbini, C
    Miller, S
    Wolter, K
    Proulx, J
    Brunell, R
    Radecki, D
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S97 - S97
  • [6] Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass
    Genant, Harry K.
    Engelke, Klaus
    Bolognese, Michael A.
    Mautalen, Carlos
    Brown, Jacques P.
    Recknor, Chris
    Goemaere, Stefan
    Fuerst, Thomas
    Yang, Yu-Ching
    Grauer, Andreas
    Libanati, Cesar
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (01) : 181 - 187
  • [7] Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women
    M. L. Frost
    M. Siddique
    G. M. Blake
    A. E. Moore
    P. K. Marsden
    P. J. Schleyer
    R. Eastell
    I. Fogelman
    Osteoporosis International, 2012, 23 : 2107 - 2116
  • [8] Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women
    Frost, M. L.
    Siddique, M.
    Blake, G. M.
    Moore, A. E.
    Marsden, P. K.
    Schleyer, P. J.
    Eastell, R.
    Fogelman, I.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 (08) : 2107 - 2116
  • [9] Bone Loading Exercises Versus Risedronate for the Prevention of Osteoporosis in Postmenopausal Women with Low Bone Mass
    Bilek, Laura
    Flores, Laura
    Kupzyk, Kevin
    Mack, Lynn
    Lappe, Joan
    Waltman, Nancy
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 196 - 196
  • [10] Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass
    Keaveny, Tony M.
    Crittenden, Daria B.
    Bolognese, Michael A.
    Genant, Harry K.
    Engelke, Klaus
    Oliveri, Beatriz
    Brown, Jacques P.
    Langdahl, Bente L.
    Yan, Chris
    Grauer, Andreas
    Libanati, Cesar
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (09) : 1956 - 1962